CompletedNot Applicable

Perineural Platelet-rich Plasma for Diabetic Neuropathy Pain

Egypt60 participantsStarted 2017-02-01

Plain-language summary

Peripheral neuropathy is very common in diabetes mellitus (DM). Till now there is no available effective therapy for this pathology. Objective: To evaluate the clinical effect of perineural platelet-rich plasma (PRP) injection as a treatment of diabetic peripheral neuropathy (DPN).

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * type II diabetes mellitus * diabetic peripheral neuropathy * six months duration of symptoms, Exclusion Criteria: * other causes of neuropathy * patient refusal * ulcers or amputations * peripheral vascular diseases * vertebral spine disease * connective tissue disease * platelet dysfunction syndrome * critical thrombocytopenia * local infection * coagulopathy

What they're measuring

visual analog scale of pain

Timeframe: 6 months

Trial details

NCT IDNCT03601494

SponsorAssiut University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-11-22

View on ClinicalTrials.gov More Diabetic Neuropathies trials